Teriparatide Does Not Exacerbate Bone Metastases in Breast Cancer Bone Metastasis Model
TPTD did not cause tumor growth, pathological fractures, or bone destruction in our <i>in vivo</i> models, indicating that it may be safe for use in breast cancer.
Authors
- Fumihito Kasama
- Yuji Kasukawa (ORCID: https://orcid.org/0000-0001-7008-675X)
- Hiroyuki Nagasawa (ORCID: https://orcid.org/0000-0001-7641-8188)
- Keita Oya
- Michio Hongo
- Hiroyuki Tsuchie (ORCID: https://orcid.org/0000-0001-5011-7184)
- Koji Nozaka (ORCID: https://orcid.org/0000-0003-0238-8929)
- TAKASHI KAWARAGI
- Naohisa Miyakoshi (ORCID: https://orcid.org/0000-0001-5175-3350)
- KENTA TOMINAGA
- Manabu Watanabe
Institutions
- Akita University (JP)
- Ome Municipal General Hospital (JP)
- Akita Industrial Technology Center (JP)
Publication Details
- Journal
- In Vivo
- Published
- 2025-06-27
- DOI
- https://doi.org/10.21873/invivo.13992
- Citations
- 2
- Primary Topic
- Bone health and treatments
- Type
- article
- Field-Weighted Citation Impact
- 2.09